Dominican Republic vs Laos: Antiretroviral therapy coverage for PMTCT
Dominican Republic
68.0%
in 2024
Laos
68.0%
in 2024
Dominican Republic rank
54th
Laos rank
54th
Antiretroviral therapy coverage for PMTCT over time
- Dominican Republic
- Laos
How they compare
Dominican Republic currently reports 68.0% against 68.0% in Laos, a difference of 0.0%.
The two have swapped places 4 times across 25 shared years of data; in 2000 it was Laos ahead.
Dominican Republic ranks 54th and Laos ranks 54th of 84 countries.
Dominican Republic has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Dominican Republic | Laos | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 16.8% | 4.2% | 12.6% | Dominican Republic |
| 2010s | 37.7% | 20.2% | 17.5% | Dominican Republic |
| 2020s | 49.8% | 44.8% | 5.0% | Dominican Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Dominican Republic or Laos?
- Dominican Republic, at 68.0% against 68.0% in Laos as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Dominican Republic and Laos?
- 0.0%, with Dominican Republic ahead.
- How many years of comparable data are there for Dominican Republic and Laos?
- 25 years are reported by both, from 2000 to 2024.
- How do Dominican Republic and Laos rank globally for antiretroviral therapy coverage for pmtct?
- Dominican Republic ranks 54th and Laos ranks 54th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).